DOJ approves $69B CVS-Aetna merger with Part D divestiture

DOJ
Aetna's Part D divestiture satisfied antitrust regulators who approved the $69 billion deal with CVS Wednesday. (skpy/Flickr)

The Department of Justice (DOJ) approved a $69 billion CVS-Aetna merger on Wednesday after Aetna agreed to sell off its Part D business. 

The Part D divestiture was a condition of the merger's approval, according to the DOJ. Late last month, Aetna agreed to sell its 2.2 million Part D business to WellCare. 

RELATED: Aetna sells Part D plans to WellCare in a 'significant step' toward closing CVS deal

FREE WEBINAR | DECEMBER 13, 2018

Employer-Based Insurance: Top Priorities for 2019

Join Blue Health Intelligence (BHI) and Midwest Business Group on Health (MBGH) to hear how key descriptive, predictive and prescriptive analytics capabilities can drive new cost and quality insights for health plans, employers and benefit consultants.